Difficulty: Medium
Average Score: 67%
Practice
Your patient is a 50-year-old man with well-controlled Type 2 diabetes and normal renal function (and no microalbuminuria). Which of the following drugs would be the most rational first choice for starting his anti-hypertensive therapy?
Correct answer
C
Rationale
In this scenario, the most rational first choice for starting anti-hypertensive therapy for a patient with well-controlled Type 2 diabetes and normal renal function is option C, an Angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker.
The rationale behind choosing an ACE inhibitor or an angiotensin receptor blocker is based on several factors:
1. **Renoprotective Effects**: ACE inhibitors and ARBs have been shown to have renoprotective effects in patients with diabetes, helping to prevent the progression of diabetic nephropathy.
2. **Cardiovascular Benefits**: These drugs have demonstrated cardiovascular benefits beyond their antihypertensive effects, reducing the risk of cardiovascular events in patients with diabetes.
3. **Reduced Risk of Hypoglycemia**: Unlike beta-blockers, ACE inhibitors and ARBs do not typically mask the symptoms of hypoglycemia in diabetic patients, making them a safer choice in this population.
4. **Guideline Recommendations**: Current guidelines recommend the use of ACE inhibitors or ARBs as first-line therapy in patients with diabetes and hypertension.
Now, let's discuss why the other options are not the most rational choices:
- **Option A (Verapamil or diltiazem)**: While calcium channel blockers like verapamil and diltiazem are effective for hypertension, they are not the preferred initial choice in patients with diabetes due to potential negative effects on glucose metabolism.
- **Option B (Beta-adrenergic blocker)**: Beta-blockers are generally not recommended as first-line agents for hypertensive patients with diabetes due to their potential to mask hypoglycemia symptoms and their association with metabolic side effects.
- **Option D (Thiazide diuretic)**: Thiazide diuretics are commonly used in hypertensive patients, but in individuals with diabetes, they may worsen glucose control and are not typically the first choice due to their metabolic effects.
Educationally, understanding the rationale behind selecting specific antihypertensive medications based on individual patient characteristics is crucial for healthcare professionals to optimize patient outcomes and minimize potential adverse effects. It highlights the importance of individualizing treatment plans based on factors such as comorbidities, renal function, and metabolic considerations.
The rationale behind choosing an ACE inhibitor or an angiotensin receptor blocker is based on several factors:
1. **Renoprotective Effects**: ACE inhibitors and ARBs have been shown to have renoprotective effects in patients with diabetes, helping to prevent the progression of diabetic nephropathy.
2. **Cardiovascular Benefits**: These drugs have demonstrated cardiovascular benefits beyond their antihypertensive effects, reducing the risk of cardiovascular events in patients with diabetes.
3. **Reduced Risk of Hypoglycemia**: Unlike beta-blockers, ACE inhibitors and ARBs do not typically mask the symptoms of hypoglycemia in diabetic patients, making them a safer choice in this population.
4. **Guideline Recommendations**: Current guidelines recommend the use of ACE inhibitors or ARBs as first-line therapy in patients with diabetes and hypertension.
Now, let's discuss why the other options are not the most rational choices:
- **Option A (Verapamil or diltiazem)**: While calcium channel blockers like verapamil and diltiazem are effective for hypertension, they are not the preferred initial choice in patients with diabetes due to potential negative effects on glucose metabolism.
- **Option B (Beta-adrenergic blocker)**: Beta-blockers are generally not recommended as first-line agents for hypertensive patients with diabetes due to their potential to mask hypoglycemia symptoms and their association with metabolic side effects.
- **Option D (Thiazide diuretic)**: Thiazide diuretics are commonly used in hypertensive patients, but in individuals with diabetes, they may worsen glucose control and are not typically the first choice due to their metabolic effects.
Educationally, understanding the rationale behind selecting specific antihypertensive medications based on individual patient characteristics is crucial for healthcare professionals to optimize patient outcomes and minimize potential adverse effects. It highlights the importance of individualizing treatment plans based on factors such as comorbidities, renal function, and metabolic considerations.